Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-034988
Filing Date
2021-09-02
Accepted
2021-09-02 20:07:25
Documents
2
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6765
2 EX-24 DOCUMENT attachment1.htm EX-24 1748
  Complete submission text file 0000899243-21-034988.txt   9954
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DANSEY ROGER D (Reporting) CIK: 0001741836 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 211234860